SCHEMBL19909130

SCHEMBL19909130

Cc1ccc2c3ccc(C)cc3n(-c3cc(-c4cc(C)nc(C)c4)cc(-n4c5cc(C)ccc5c5ccc(C)cc54)c3C#N)c2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.34
KDR P35968 1/20 0.34
AURKB Q96GD4 1/20 0.34
THRB P10828 1/20 0.34
KDM4E B2RXH2 9/20 0.34
HPGD P15428 5/20 0.34
ALDH1A1 P00352 5/20 0.34
HSD17B10 Q99714 3/20 0.34
NCOA1 Q15788 2/20 0.33
NCOA3 Q9Y6Q9 2/20 0.33
LMNA P02545 2/20 0.33
POLB P06746 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HIF1A Q16665 1/20 0.33
NPSR1 Q6W5P4 3/20 0.33
PPARG P37231 2/20 0.33
STAT3 P40763 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NR2E3 Q9Y5X4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909132 0.94 PDE9A (0.37) THRBKDM4EHPGDALDH1A1HSD17B10
SCHEMBL19909222 0.91 AURKA (0.38) AURKAKDRAURKBKDM4EHPGD
SCHEMBL19913307 0.89 POLB (0.37) KDM4ENCOA1NCOA3LMNAPOLB
SCHEMBL22563686 0.89 NPSR1 (0.34) AURKAKDRAURKBTHRBKDM4E
SCHEMBL23296385 0.89 LMNA (0.36) AURKAKDRAURKBTHRBKDM4E
SCHEMBL19913310 0.88 KDM5B (0.42) AURKAKDRAURKBKDM4EHPGD
SCHEMBL19909223 0.88 ABL1 (0.35) AURKAKDRAURKBTHRBKDM4E
SCHEMBL22170313 0.88 CYP11B2 (0.37) KDM4EHPGDALDH1A1HSD17B10NPSR1
SCHEMBL19909437 0.87 KDM5B (0.42) KDM4EHPGDALDH1A1HSD17B10POLB
SCHEMBL21279125 0.86 KDM4E (0.33) AURKAKDRAURKBTHRBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 AURKA 2834/4885KDR 445/4885AURKB 2958/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 AURKA 2834/4885KDR 445/4885AURKB 2958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.